Literature DB >> 9309400

Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma.

D A Antonioli1, H H Wang.   

Abstract

This article has reviewed the morphologic features of BE and its complications of dysplasia and adenocarcinoma in routinely processed endoscopic biopsy and resection specimens. In addition, the problems related to the diagnosis of dysplasia in tissue samples have been analyzed, and the role of esophageal brush cytology in the diagnosis of these lesions has been reviewed.

Entities:  

Mesh:

Year:  1997        PMID: 9309400     DOI: 10.1016/s0889-8553(05)70309-5

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  8 in total

Review 1.  Pathology of Barrett's esophagus.

Authors:  R C Haggitt
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

Review 2.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

3.  Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.

Authors:  Hector Alvarez; Pamela Leal Rojas; Ken-Tye Yong; Hong Ding; Gaixia Xu; Paras N Prasad; Jean Wang; Marcia Canto; James R Eshleman; Elizabeth A Montgomery; Anirban Maitra
Journal:  Nanomedicine       Date:  2008-08-08       Impact factor: 5.307

4.  p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.

Authors:  J F Fléjou; V Gratio; F Muzeau; R Hamelin
Journal:  Mol Pathol       Date:  1999-10

5.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.

Authors:  Xia Wang; Hong Ouyang; Yusuke Yamamoto; Pooja Ashok Kumar; Tay Seok Wei; Rania Dagher; Matthew Vincent; Xin Lu; Andrew M Bellizzi; Khek Yu Ho; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

6.  Dysplasia in Barrett's Esophagus.

Authors:  Marcos Pedrosa
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

7.  Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

Authors:  L J Williams; D L Guernsey; A G Casson
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

8.  Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.

Authors:  M T Salmela; M L Karjalainen-Lindsberg; P Puolakkainen; U Saarialho-Kere
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.